跳至主要内容
临床试验/CTRI/2020/09/028121
CTRI/2020/09/028121招募中2 期

Evaluation of Efficacy and Safety of AYUSH- M3 in the management ofPre-Hypertension â?? A Double blind Randomized control clinical study

CCRAS0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
招募中
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Patients of either sex aged 30-65 years.
  • Diagnosed patients of Pre hypertension as per 7th report of JNC
  • (120-139 of Hg SBP or 80-89 mm of Hg DBP)
  • Willing and able to participate for 3 months

排除标准

  • Patients who have history of Cardiac Arrhythmia, Acute Coronary Syndrome, Myocardial Infarction, congestive cardiac failure ,Stroke or Severe Arrhythmia in the last 6 months.
  • Essential Hypertension / Secondary hypertension.
  • Patients with concurrent Hepatic Dysfunction (defined as AST and/or ALT > 2 times of the upper normal limit) or Renal Dysfunction (defined as S. creatinine > 1.2 mg/dl),uncontrolled Pulmonary Dysfunction (asthmatic and COPD patients) or major systemic illness necessitating long term drug treatment (Rheumatoid arthritis, Neurological disorders, Endocrinal disorders, etc.) or Known cases of malignancy
  • Uncontrolled Diabetes Mellitus(HbA1C >8)
  • Women who are planning for conception / pregnant or lactating.
  • H/o hypersensitivity to any of the trial drugs or their ingredients.
  • Patient taking participation in any other clinical trial.
  • Any other condition which the P.I. thinks may jeopardize the study.

研究者

发起方
CCRAS

相似试验